DISCUSSION OF CONCEPTS OF THERAPY - PREVENTION AND MANAGEMENT OF OSTEODYSTROPHY IN PATIENTS WITH LONG-TERM HEMODIALYSIS

被引：0
|
作者：
LEONARDS, J
RICH, C
KAYE
HEANEY, R
WELT, LG
AURBACH, G
KLEEMAN, C
STANBURY, S
NICHOLS, G
SHERWOOD, L
机构：
来源：
ARCHIVES OF INTERNAL MEDICINE | 1969年 / 124卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：660 / &
相关论文
共 50 条
  • [41] Anti-Toxoplasma gondii antibodies in hemodialysis patients receiving long-term hemodialysis therapy in Turkey
    Ocak, S
    Duran, N
    Eskiocak, AF
    Aytac, H
    SAUDI MEDICAL JOURNAL, 2005, 26 (09) : 1378 - 1382
  • [42] Malaria prevention and management for long-term travellers
    Schlagenhauf, P.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 : 16 - 16
  • [43] MANAGEMENT OF LONG-TERM ANTICOAGULANT THERAPY
    VIGRAN, IM
    GERIATRICS, 1963, 18 (12) : 916 - +
  • [44] LONG-TERM EXPERIENCE OF ALFACALCIDOL IN RENAL OSTEODYSTROPHY
    SHARMAN, VL
    BROWNJOHN, AM
    GOODWIN, FJ
    HATELY, W
    MANNING, RM
    ORIORDAN, JHL
    PAPAPOULOS, SE
    MARSH, FP
    QUARTERLY JOURNAL OF MEDICINE, 1982, 51 (203): : 271 - 278
  • [45] LONG-TERM EXPERIENCE OF ALFACALCIDOL IN RENAL OSTEODYSTROPHY
    SHARMAN, VL
    BROWNJOHN, AM
    HATELY, W
    ORIORDAN, JLH
    PAPAPOULOS, SE
    GOODWIN, FJ
    MARSH, FP
    KIDNEY INTERNATIONAL, 1981, 20 (02) : 316 - 316
  • [46] ALLERGY IN LONG-TERM HEMODIALYSIS .2. ALLERGIC AND ATOPIC PATTERNS OF A POPULATION OF PATIENTS UNDERGOING LONG-TERM HEMODIALYSIS
    BOUSQUET, J
    MAURICE, F
    RIVORY, JP
    SKASSABROCIEK, W
    FLORENCE, P
    CHOUZENOUX, R
    MION, C
    MICHEL, FB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (03) : 590 - 597
  • [47] Comparison of three methods for the detemination of body fat in patients on long-term hemodialysis therapy
    Kamimura, MY
    Dos Santos, NSJ
    Avesani, CM
    Canziani, MEF
    Draibe, SA
    Cuppari, L
    JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2003, 103 (02) : 195 - 199
  • [48] Long-term effects of etelcalcetide as intravenous calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism
    Shigematsu, Takashi
    Fukagawa, Masafumi
    Yokoyama, Keitaro
    Akiba, Takashi
    Fujii, Akifumi
    Odani, Motoi
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (02) : 426 - 436
  • [49] Long-Term Low-Dose Spironolactone Therapy Is Safe in Oligoanuric Hemodialysis Patients
    Matsumoto, Yoshihiro
    Kageyama, Shinji
    Yakushigawa, Toru
    Arihara, Kazuo
    Sugiyama, Toshikazu
    Mori, Yasuo
    Sugiyama, Hatsumi
    Ohmura, Hiromichi
    Shio, Nobuo
    CARDIOLOGY, 2009, 114 (01) : 32 - 38
  • [50] LONG-TERM DENOPAMINE THERAPY FOR HEMODIALYSIS-PATIENTS WITH CHRONIC HEART-FAILURE
    TAKATA, Y
    TSUCHIHASHI, T
    NAKAMURA, S
    HIROTA, Y
    CLINICAL CARDIOLOGY, 1995, 18 (07) : 408 - 411
12345